MoonLake Immunotherapeutics (MLTX)
45.26
+2.69
(+6.32%)
USD |
NASDAQ |
May 03, 16:00
45.23
-0.03
(-0.07%)
After-Hours: 20:00
MoonLake Immunotherapeutics Price to Book Value: 5.741 for May 3, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 03, 2024 | 5.741 |
| May 02, 2024 | 5.400 |
| May 01, 2024 | 5.434 |
| April 30, 2024 | 5.189 |
| April 29, 2024 | 5.298 |
| April 26, 2024 | 5.390 |
| April 25, 2024 | 5.359 |
| April 24, 2024 | 5.382 |
| April 23, 2024 | 5.486 |
| April 22, 2024 | 5.203 |
| April 19, 2024 | 5.352 |
| April 18, 2024 | 5.359 |
| April 17, 2024 | 5.519 |
| April 16, 2024 | 5.518 |
| April 15, 2024 | 5.536 |
| April 12, 2024 | 5.570 |
| April 11, 2024 | 5.790 |
| April 10, 2024 | 5.858 |
| April 09, 2024 | 5.930 |
| April 08, 2024 | 5.869 |
| April 05, 2024 | 5.983 |
| April 04, 2024 | 5.834 |
| April 03, 2024 | 5.831 |
| April 02, 2024 | 5.994 |
| April 01, 2024 | 6.165 |
| Date | Value |
|---|---|
| March 28, 2024 | 6.372 |
| March 27, 2024 | 6.369 |
| March 26, 2024 | 6.352 |
| March 25, 2024 | 6.563 |
| March 22, 2024 | 6.596 |
| March 21, 2024 | 6.643 |
| March 20, 2024 | 6.279 |
| March 19, 2024 | 6.417 |
| March 18, 2024 | 6.160 |
| March 15, 2024 | 5.994 |
| March 14, 2024 | 5.553 |
| March 13, 2024 | 5.695 |
| March 12, 2024 | 5.84 |
| March 11, 2024 | 5.968 |
| March 08, 2024 | 5.786 |
| March 07, 2024 | 5.782 |
| March 06, 2024 | 5.735 |
| March 05, 2024 | 6.101 |
| March 04, 2024 | 6.198 |
| March 01, 2024 | 6.459 |
| February 29, 2024 | 6.119 |
| February 28, 2024 | 6.930 |
| February 27, 2024 | 6.680 |
| February 26, 2024 | 6.358 |
| February 23, 2024 | 6.350 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
3.052
Minimum
Jun 30 2022
53.83
Maximum
Jun 27 2023
9.755
Average
6.500
Median
Price to Book Value Benchmarks
| Qiagen NV | 2.649 |
| LENZ Therapeutics Inc | -- |
| AC Immune SA | 1.236 |
| CRISPR Therapeutics AG | 2.520 |
| Addex Therapeutics Ltd | 7.014 |
Price to Book Value Related Metrics
| Price | 45.26 |
| Earnings Yield | -1.64% |
| Market Cap | 2.846B |